You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Johnson and Johnson
Pharmaceuticals
Sanofi
AstraZeneca
GSK
Pfizer
Novartis
Valneva
Novo Nordisk
AbbVie
Topics

Advertisement

Johnson and Johnson

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

Johnson & Johnson becomes oversold (JNJ) Nasdaq 4d

Nasdaq 4d

High court won't hear 3rd circuit j&j class cert appeal Law360 4d

Law360 4d

Johnson & Johnson consumer v. Noohi Public Citizen 4d

Public Citizen 4d

Advertisement

J&J denied supreme court review of investor class certification Bloomberg Law 4d

Bloomberg Law 4d

Advertisement

Is Johnson & Johnson a buy after its Q1 2026 Earnings Report? The Motley Fool 6d

The Motley Fool 6d

Bayer loses bid to block j&j's Cancer Drug survival claims Law360 6d

Law360 6d

Advertisement

Advertisement

Latest

In the last 4 hours

J&J’s Icotyde approved by US FDA for plaque psoriasis PMLiVE 10:55

In the last 8 hours

Johnson & Johnson's Imaavy Shows Two Years Of Gmg Control RTT News 08:39

Earlier Today

Johnson & Johnson Launches AI-Driven Cardiac Mapping System Hospimedica 06:11

Yesterday

Inside the Viz.ai–J&J deal to speed subdural hemorrhage care, from CT scan to treatment decision Drug Discovery & Development 18:00 Thu, 23 Apr

Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care Business Wire (Press Release) 14:02 Thu, 23 Apr

J&J secures CE mark for ETHICON 4000 Stapler Verdict Medical Devices 11:28 Thu, 23 Apr

IMAAVY Data And AI MedTech Launch Test Johnson & Johnson Dividend Story Simply Wall St 11:01 Thu, 23 Apr

Why This Popular Core Stock Is a Sell MorningStar.com 10:26 Thu, 23 Apr

Wednesday

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks 15:00 Wed, 22 Apr

Johnson & Johnson: New Data Reinforces Efficacy, Sustained Disease Control Of Imaavy RTT News 13:51 Wed, 22 Apr

Advertisement

Advertisement

Advertisement

Advertisement

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis